Immune-related adverse events associated with nab-paclitaxel/paclitaxel combined with immune checkpoint inhibitors: a systematic review and network meta-analysis

OBJECTIVE: The combination of nanoparticle albumin-bound paclitaxel (nab-PTX)/paclitaxel (PTX) with immune checkpoint inhibitors (ICIs) has demonstrated significant efficacy in cancer patients. However, the safety of these combination regimens remains conflicting in former researches. Therefore, in...

Descripción completa

Detalles Bibliográficos
Autores principales: Hao, Wenjing, Zhang, Jun, Wang, Yunxia, Fang, Boyu, Jin, Shasha, Yuan, Jing, Cai, Weimin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10375236/
https://www.ncbi.nlm.nih.gov/pubmed/37520574
http://dx.doi.org/10.3389/fimmu.2023.1175809

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10375236/
https://www.ncbi.nlm.nih.gov/pubmed/37520574
http://dx.doi.org/10.3389/fimmu.2023.1175809

Ejemplares similares